000 01190 a2200337 4500
005 20250516063058.0
264 0 _c20120406
008 201204s 0 0 eng d
022 _a1872-9061
040 _aNLM
_beng
_cNLM
100 1 _aHak, A E
245 0 0 _aDermatomyositis and polymyositis: new treatment targets on the horizon.
_h[electronic resource]
260 _bThe Netherlands journal of medicine
_cOct 2011
300 _a410-21 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xtherapeutic use
650 0 4 _aDermatomyositis
_xcomplications
650 0 4 _aGlucocorticoids
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xtherapeutic use
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aInterferon-alpha
_xantagonists & inhibitors
650 0 4 _aPolymyositis
_xcomplications
650 0 4 _aRituximab
650 0 4 _aTumor Necrosis Factor Inhibitors
700 1 _ade Paepe, B
700 1 _ade Bleecker, J L
700 1 _aTak, P-P
700 1 _ade Visser, M
773 0 _tThe Netherlands journal of medicine
_gvol. 69
_gno. 10
_gp. 410-21
999 _c21287932
_d21287932